Testing times! Choosing Wisely when it comes to monitoring type 2 diabetes | Zendy

Speight Jane | Zendy; Browne Jessica L | Zendy; Furler John S | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Testing times! Choosing Wisely when it comes to monitoring type 2 diabetes

Author(s) -

Speight Jane,

Browne Jessica L,

Furler John S

Publication year - 2015

Publication title -

medical journal of australia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.904

H-Index - 131

eISSN - 1326-5377

pISSN - 0025-729X

DOI - 10.5694/mja15.00639

Subject(s) - research centre , library science , citation , diabetes mellitus , sociology , medicine , computer science , endocrinology

The Cochrane review included 12 RCTs (3249 participants). Among these, nine trials of 6 months’ duration found that glycated haemoglobin (HbA1c) levels were reduced on average by 0.3% (a statistically, but not clinically, significant improvement). There was no significant reduction in HbA1c levels in trials with 12 months of follow-up. Overall, no benefit was shown for patient satisfaction, emotionalwellbeingor health-related quality of life, and SMBG was considered unlikely to be cost-effective.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research